Organization: Health Canada
Year: 2023
Month: September
Request Number: A-2021-001604
Request Summary: For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, the letters from Health Canada to all applicant companies, including the letter from Health Canada confirming receipt of the submission.
Disposition: Disclosed in part
Number of pages: 14